Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Organ Transplantation | 11 | 2021 | 2616 | 1.89 | Why? |
| Transplant Recipients | 13 | 2021 | 4982 | 1.78 | Why? |
| Immunogenicity, Vaccine | 5 | 2021 | 4624 | 1.05 | Why? |
| Living Donors | 4 | 2020 | 652 | 0.98 | Why? |
| Tissue and Organ Procurement | 3 | 2020 | 1277 | 0.87 | Why? |
| Kidney Transplantation | 10 | 2021 | 5397 | 0.66 | Why? |
| Vaccines, Synthetic | 4 | 2021 | 3231 | 0.64 | Why? |
| Antibodies, Viral | 14 | 2021 | 51949 | 0.62 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.57 | Why? |
| Musculoskeletal Diseases | 3 | 2021 | 646 | 0.39 | Why? |
| Renal Insufficiency | 3 | 2021 | 810 | 0.38 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.32 | Why? |
| Tissue Donors | 3 | 2020 | 1679 | 0.32 | Why? |
| Patient Safety | 1 | 2021 | 4885 | 0.30 | Why? |
| Waiting Lists | 4 | 2020 | 1388 | 0.29 | Why? |
| Liver Transplantation | 4 | 2021 | 2864 | 0.28 | Why? |
| Vaccination | 5 | 2021 | 19050 | 0.24 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.23 | Why? |
| Rheumatic Diseases | 3 | 2021 | 2675 | 0.22 | Why? |
| Registries | 2 | 2020 | 12327 | 0.22 | Why? |
| Immunocompromised Host | 3 | 2021 | 5150 | 0.20 | Why? |
| Abatacept | 1 | 2021 | 192 | 0.20 | Why? |
| Immunoenzyme Techniques | 1 | 2021 | 448 | 0.19 | Why? |
| Antibody Formation | 5 | 2021 | 4038 | 0.17 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.17 | Why? |
| Graft Survival | 1 | 2020 | 587 | 0.17 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.16 | Why? |
| United States | 8 | 2021 | 46150 | 0.16 | Why? |
| Aircraft | 1 | 2020 | 498 | 0.15 | Why? |
| Tissue and Organ Harvesting | 1 | 2017 | 146 | 0.15 | Why? |
| Immunosuppressive Agents | 4 | 2021 | 6331 | 0.15 | Why? |
| Kidney Failure, Chronic | 2 | 2020 | 3222 | 0.13 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.13 | Why? |
| Adult | 15 | 2021 | 244371 | 0.13 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.13 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.12 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.12 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.12 | Why? |
| Humans | 31 | 2021 | 930598 | 0.11 | Why? |
| Male | 18 | 2021 | 367725 | 0.11 | Why? |
| Female | 18 | 2021 | 380317 | 0.11 | Why? |
| Immune System | 1 | 2021 | 1479 | 0.11 | Why? |
| Heart Transplantation | 1 | 2021 | 1293 | 0.11 | Why? |
| Graft Rejection | 1 | 2021 | 1766 | 0.11 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.10 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.09 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.09 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.09 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.09 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.09 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.08 | Why? |
| Aged | 10 | 2021 | 215776 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.08 | Why? |
| HIV Infections | 2 | 2021 | 11620 | 0.07 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.07 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.06 | Why? |
| Infant | 3 | 2020 | 30274 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.06 | Why? |
| Postoperative Complications | 1 | 2020 | 5861 | 0.06 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.06 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Health Behavior | 1 | 2017 | 4449 | 0.05 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Symptom Flare Up | 1 | 2021 | 432 | 0.04 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.04 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Nephrectomy | 1 | 2017 | 406 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.02 | Why? |
| Developing Countries | 1 | 2021 | 4283 | 0.02 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |